Who Owns Haemonetics Stock?
NYSE: HAEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.46%
- Institutions (% of float)
- 113.90%
- Held by insiders
- 1.26%
- Institutional holders
- 465
- Institutions 98.7%
- Insiders 1.3%
- Public and other 0.0%
Who owns Haemonetics stock?
Institutional investors own about 112.5% of Haemonetics's shares, spread across 465 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.26% of HAE.
The largest institutional holders are Blackrock Inc. (12.99%), Neuberger Berman Group, LLC (9.19%) and Vanguard Portfolio Management LLC (5.60%). Together, the top 10 institutions control 55.5% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their HAE positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of HAE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.91M | 12.99% | +5.2% |
| Neuberger Berman Group, LLC | 4.18M | 9.19% | +17.4% |
| Vanguard Portfolio Management LLC | 2.55M | 5.60% | -0.5% |
| AQR Capital Management, LLC | 2.27M | 4.98% | -32.5% |
| Ariel Investments, LLC | 2.06M | 4.53% | +100.0% |
| Vanguard Capital Management LLC | 2.06M | 4.53% | -1.5% |
| State Street Corporation | 1.82M | 4.00% | +2.5% |
| Dimensional Fund Advisors LP | 1.59M | 3.48% | +19.5% |
| Citadel Advisors Llc | 1.51M | 3.32% | +485.0% |
| Geode Capital Management, LLC | 1.29M | 2.83% | +5.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of HAE
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 1.63M | 3.58% |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 1.49M | 3.28% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.44M | 3.17% |
| iShares Trust-iShares Russell 2000 ETF | 1.21M | 2.66% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.04M | 2.29% |
| Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com | 614.82K | 1.35% |
| Ariel Investment Trust-Ariel Fund | 573.66K | 1.26% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 533.21K | 1.17% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 515.27K | 1.13% |
| iShares Trust-iShares Russell 2000 Growth ETF | 416.11K | 0.91% |
Frequently asked questions
Who is the largest shareholder of Haemonetics?
Blackrock Inc. is the largest institutional shareholder of HAE, owning 12.99% of shares outstanding (5.91M shares) as of its latest 13F filing.
What percentage of Haemonetics is owned by institutions?
Institutions own about 112.5% of HAE shares and 113.9% of the public float.
How much of Haemonetics do insiders own?
Insiders, such as officers and directors, own about 1.26% of HAE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.